Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
The present invention provides a potent inhibitor of protein glycation and AGEs formation that is particularly advantageous for eye-drop delivery in the prevention and treatment of diabetes- and age-related pathologies. More
Our client is looking for partners to further develop and commercialize stem cells, sourced from adipose tissue for the treatment of regenerative medicine and ageing. More
Ophthalmologic Surgery More
Diabetic retinopathy is one of the most common microvascular complications of diabetes, affecting nearly 50% of patients with diabetes. Diabetic retinopathy can affect almost anyone with diabetes, while an additional 5.4 million have undiagnosed dia More
The antibody detects a protein of Candida famata and is useful for detection of candidiasis and retinopathies in samples from blood, urine, aqueous humour, vitreous humour, and cerebral spinal fluid without interference from other species of Candida More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Bitter taste receptor with potential application for improvement/masking of taste in foods and drugs More
Effective treatment options for diseases such as Alzheimer's, Parkinson's, and cataracts are needed. This new group of compounds have the potential to treat disorders caused by oxidative stress by functioning as antioxidants and metal chelators. More
Balanced salt solution (BSS) audible alarm device More
Related Reports
Market Research Reports provided by reports.innovaro.com
Wrigley's 5 Gum Case Study: remaining competitive in the gum market through a multi-sensory offering
Aug 2009 - 10 pages - $295
Jun 2006 - 422 pages - $2,495
Apr 2010 - 510 pages - $2,695
Oct 2011 - 64 pages - $500
Apr 2011 - 951 pages - $4,995
Oct 2010 - 598 pages - $2,695
Sep 2010 - 118 pages - $3,835
Feb 2008 - 44 pages - $495
Mar 2011 - 21 pages - $750
Jun 2008 - 9 pages - $295
Your selection
- Therapeutic target
- Sensory organ del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Auditory
- Opthalmic
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us